Regenerx Biopharmaceuticals Inc
RGRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000707511
Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Regenerx Biopharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 210.3K | 210.0K | −300 (−0.1%) |
| Value | $57.0K | $35.0K | −$22.0K (−38.6%) |
New holders (0)
Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (1)
Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Steward Partners Investment Advisory, LLC | 300 | $0 |